PARP Inhibitors for the Treatment and Prevention of Breast Cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1007/s12609-010-0026-0.pdf
Reference36 articles.
1. Ford JM, Kastan MB: DNA damage response pathways and cancer. In Abeloff’s Clinical Oncology. Edited by Abeloff MD. Philadelphia: Churchill Livingstone; 2008:139–152.
2. Spry M, Scott T, Pierce H, D’Orazio JA: DNA repair pathways and hereditary cancer susceptibility syndromes. Front Biosci 2007, 12:4191–4207.
3. Rowe BP, Glazer PM: Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms. Breast Cancer Res 2010, 12:203.
4. Curtin NJ: PARP inhibitors for cancer therapy. Expert Rev Mol Med 2005, 7:1–20.
5. Rouleau M, Patel A, Hendzel MJ, et al.: PARP inhibition: PARP1 and beyond. Nat Rev Cancer 2010, 10:293–301.
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies;Frontiers in Oncology;2024-05-28
2. Contraception as chemoprevention of ovarian cancer in BRCA1 and BRCA2 women;Hormones;2023-12-19
3. Advances in the Prevention and Treatment of Obesity-Driven Effects in Breast Cancers;Frontiers in Oncology;2022-06-22
4. Biochemical, Structural Analysis, and Docking Studies of Spiropyrazoline Derivatives;International Journal of Molecular Sciences;2022-05-27
5. New Perspectives on the Recurrent BRCA Mutations and Clinical Variability;International Journal of Hematology and Oncology;2022-03-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3